Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04628767
Title Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Durvalumab + Gemcitabine

Cisplatin + Doxorubicin + Methotrexate + Pegfilgrastim + Vinblastine

Cisplatin + Doxorubicin + Durvalumab + Methotrexate + Pegfilgrastim + Vinblastine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.